Bank Of America Corp Athenex, Inc. Transaction History

Bank Of America Corp

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	SELL	$0.12 - $0.21 $1 - $1	-9 Reduced 0.01%	62,413 $9,000
Q3 2022 Nov 14, 2022	SELL	$0.24 - $1.11 $14,559 - $67,339	-60,666 Reduced 49.29%	62,422 $17,000
Q2 2022 Aug 12, 2022	BUY	$0.41 - $0.91 $9,928 - $22,037	24,217 Added 24.49%	123,088 $50,000
Q1 2022 May 16, 2022	BUY	$0.79 - $1.59 $13,409 - $26,988	16,974 Added 20.73%	98,871 $82,000
Q4 2021 Feb 08, 2022	SELL	$1.36 - $2.94 $55,821 - $120,672	-41,045 Reduced 33.39%	81,897 $110,000
Q3 2021 Nov 15, 2021	BUY	$2.97 - $4.84 $168,592 - $274,742	56,765 Added 85.78%	122,942 $370,000
Q2 2021 Sep 13, 2021	BUY	$3.71 - $5.13 $245,516 - $339,488	66,177 New	66,177 $306,000

1.46M

Ticker ATNX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 156,790,000
Market Cap $1.57M
Description
Athenex, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of cancer. It operates through three segments: Oncology Innovation Platform, Global Supply Chain Platform, and Commercial Platform. The company's Orascovery product candidates include Oral paclitaxel and encequidar,...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.